Menu

Blog

Archive for the ‘biotech/medical’ category: Page 996

Apr 4, 2022

Deleting a Protein May Prevent Heart Attacks and Strokes

Posted by in categories: biotech/medical, health

Macrophages travel through our arteries, gobbling fat the way Pac-man gobbled ghosts. But fat-filled macrophages can narrow blood vessels and cause heart disease. Now, UConn Health researchers describe in Nature Cardiovascular Research how deleting a protein could prevent this and potentially prevent heart attacks and strokes in humans.

Macrophages are large white blood cells that cruise through our body as a kind of clean-up crew, clearing hazardous debris. But in people with atherosclerosis—fatty deposits and inflammation in their blood vessels— macrophages can cause trouble. They eat excess fat inside artery walls, but that fat causes them to become foamy. And foamy macrophages tend to encourage inflammation in the arteries and sometimes bust apart plaques, freeing clots that can cause heart attack, stroke, or embolisms elsewhere in the body.

Changing how macrophages express a certain protein could prevent that kind of bad behavior, reports a team of researchers from UConn Health. They found that the protein, called TRPM2, is activated by inflammation. It signals macrophages to start eating fat. Since inflammation of the blood vessels is one of the primary causes of atherosclerosis, TRPM2 gets activated quite a bit. All that TRPM2 activation pushes macrophage activity, which leads to more foamy macrophages and potentially more inflamed arteries. The way that TRPM2 activated macrophage activity was surprising, says Lixia Yue, a UConn School of Medicine cell biologist.

Apr 4, 2022

How a Seagen cancer drug with Nobel Prize science might also work in diabetes

Posted by in categories: biotech/medical, science

Some diabetes therapies work by ramping up the body’s secretion of insulin to counteract high blood sugar levels. | Preserving insulin-producing pancreatic beta cells—rather than exhausting them—might be a better strategy in the treatment of diabetes. Following that thinking, scientists at the Karolinska Institute found a cancer drug by Seagen holds promise for the metabolic disease.

Apr 3, 2022

Surgeons implant printed earlobe in a work-accident victim

Posted by in category: biotech/medical

A 55-year-old man who lost half of his external ear in a work accident in a carpentry shop that couldn’t be reattached nevertheless has a new ear lobe instead.

Plastic surgeons at Jerusalem’s Shaare Zedek Medical Center (SZMC) used advanced technology and artificial cartilage to sculpt a new earlobe and implant it on the side of the accident victim’s head.

The patient was rushed to SZMC’s emergency department after a wooden surface fell on him and caused the loss of the upp… See more.

Continue reading “Surgeons implant printed earlobe in a work-accident victim” »

Apr 3, 2022

Tiny Experimental Implant Could Treat Neuropathic Pain

Posted by in category: biotech/medical

𝐏𝐚𝐢𝐧 𝐍𝐞𝐰𝐬 𝐍𝐞𝐭𝐰𝐨𝐫𝐤:

The Neuro-Network.

𝐓𝐢𝐧𝐲 𝐄𝐱𝐩𝐞𝐫𝐢𝐦𝐞𝐧𝐭𝐚𝐥 𝐈𝐦𝐩𝐥𝐚𝐧𝐭 𝐂𝐨𝐮𝐥𝐝 𝐓𝐫𝐞𝐚𝐭 𝐍𝐞𝐮𝐫𝐨𝐩𝐚𝐭𝐡𝐢𝐜 𝐏𝐚𝐢𝐧

Continue reading “Tiny Experimental Implant Could Treat Neuropathic Pain” »

Apr 3, 2022

Mark Zuckerberg — Founder and CEO of Meta | The Tim Ferriss Show

Posted by in categories: augmented reality, biotech/medical, business, computing, virtual reality

It’s a reference to the evil form in the ‘Lord of the Rings’ books. For those unfamiliar with the ‘Lord of the Rings” books and movies, the Eye of Sauron is the chief antagonist in the series, exemplified as a flaming eye and that is a metaphor for pure evil. It’s not something anyone would want to be compared to unless, of course, you are Meta founder and CEO Mark Zuckerberg.


Mark Zuckerberg on Long-Term Strategy, Business and Parenting Principles, Personal Energy Management, Building the Metaverse, Seeking Awe, the Role of Religion, Solving Deep Technical Challenges (e.g., AR), and More | Brought to you by Eight Sleep’s Pod Pro Cover sleeping solution for dynamic cooling and heating (http://eightsleep.com/Tim), Magic Spoon delicious low-carb cereal (http://magicspoon.com/tim), and Helium 10 all-in-one software suite to sell on Amazon (https://helium10.com/tim).

Continue reading “Mark Zuckerberg — Founder and CEO of Meta | The Tim Ferriss Show” »

Apr 3, 2022

HIF-1α inhibitor PX-478 preserves pancreatic β cell function in diabetes

Posted by in category: biotech/medical

PX-478 improves insulin secretion in mouse and human organoid models of diabetes.

Apr 3, 2022

The Biggest Revolution Since the Computer Is Here — Synthetic Biology 🧫

Posted by in categories: bioengineering, biological, biotech/medical, computing, finance

Innovations in computing tech have improved the accuracy of DNA synthesis and enabled synthetic biology to work in the real world.


I don’t know about you, but I’m constantly looking for the “next big thing” in the stock market. And I think synthetic biology might just be it.

Why? If you invested just $10,000 into any of those world-changing stocks back in their early days, you’d have MILLIONS today. Forget the Iraq War, the housing crash, the European debt crisis. Forget the pandemic and the Russia-Ukraine war. Through it all, you’d have millions today.

Continue reading “The Biggest Revolution Since the Computer Is Here — Synthetic Biology 🧫” »

Apr 3, 2022

Clinical Trials Targeting Aging

Posted by in categories: biotech/medical, life extension

A miniature review of.


The risk of morbidity and mortality increases exponentially with age. Chronic inflammation, accumulation of DNA damage, dysfunctional mitochondria, and increased senescent cell load are factors contributing to this. Mechanistic investigations have revealed specific pathways and processes which, proposedly, cause age-related phenotypes such as frailty, reduced physical resilience, and multi-morbidity. Among promising treatments alleviating the consequences of aging are caloric restriction and pharmacologically targeting longevity pathways such as the mechanistic target of rapamycin (mTOR), sirtuins, and anti-apoptotic pathways in senescent cells. Regulation of these pathways and processes has revealed significant health-and lifespan extending results in animal models. Nevertheless, it remains unclear if similar results translate to humans. A requirement of translation are the development of age-and morbidity associated biomarkers as longitudinal trials are difficult and not feasible, practical, nor ethical when human life span is the endpoint. Current biomarkers and the results of anti-aging intervention studies in humans will be covered within this paper. The future of clinical trials targeting aging may be phase 2 and 3 studies with larger populations if safety and tolerability of investigated medication continues not to be a hurdle for further investigations.

As age increases, so does the susceptibility to a series of chronic diseases which ultimately result in fatal endings. This is such a basic part of life that we rarely consider if there is anything we can do to postpone it. So far, the principal of “one-disease-one-treatment” has brought medical sciences far but this line of thought may soon be outdated when it comes to aging related conditions. It is like fighting a many-headed monster: If one condition is treated successfully, another emerges shortly after. This point is illustrated as eradicating the two leading causes of death (cancer and cardiovascular disease) extends mean life span by 3.3 and 4 years, respectively (Arias et al., 2013). Interestingly, the gain of treating multiple diseases combined exceeds the sum of these numbers.

Continue reading “Clinical Trials Targeting Aging” »

Apr 3, 2022

Blood Test #2 in 2022: Diet

Posted by in categories: biotech/medical, life extension

Join us on Patreon!
https://www.patreon.com/MichaelLustgartenPhD

Levine’s Biological age calculator is embedded as an Excel file in this link from my website:
https://michaellustgarten.com/2019/09/09/quantifying-biological-age/

Apr 3, 2022

Is Aging Reversible? A Scientific Look with David Sinclair | David Sinclair | TEDxBoston

Posted by in categories: biotech/medical, genetics, life extension

NOTE FROM TED: Research around aging discussed in this talk remains an ongoing field of study. Please do not look to this talk for health advice. TEDx events are independently organized by volunteers. The guidelines we give TEDx organizers are described in more detail here: http://storage.ted.com/tedx/manuals/tedx_content_guidelines.pdf.

Have you ever wondered how long you will live? And if so, how could you change that number to live drastically longer? The science might be in your favor: follow David Sinclair, Australian biologist and professor of genetics at Harvard University, as he shares his research on slowing and reversing the process of aging in mice, and how the same technology may someday be transferable to humans. David Sinclair, Australian biologist and professor of genetics at Harvard Universityhis insightful research into the science of age reversal and anti-aging medicine.

Continue reading “Is Aging Reversible? A Scientific Look with David Sinclair | David Sinclair | TEDxBoston” »